SCHEMBL650959

SCHEMBL650959

Cc1cc(OCCN(C)C)ccc1/N=C1/NC(=O)/C(=C/c2cnc(C3CCCCN3)s2)S1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.38
NPSR1 Q6W5P4 4/20 0.38
RECQL P46063 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MAPK1 P28482 1/20 0.37
PIK3CA P42336 1/20 0.37
PRKDC P78527 1/20 0.37
HPGD P15428 5/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 2/20 0.35
ALOX15 P16050 2/20 0.34
PTGS2 P35354 2/20 0.34
PTPN11 Q06124 1/20 0.34
KMT2A Q03164 2/20 0.33
PSMD14 O00487 1/20 0.33
MEN1 O00255 1/20 0.33
PPARG P37231 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PTP4A3 O75365 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL650961 1.00 MAPT (0.38) MAPTNPSR1RECQLTDP1L3MBTL1
SCHEMBL649312 0.87 HPGD (0.43) MAPTNPSR1RECQLTDP1L3MBTL1
SCHEMBL649314 0.87 HPGD (0.43) MAPTNPSR1RECQLTDP1L3MBTL1
SCHEMBL653423 0.84 MAPT (0.39) MAPTNPSR1RECQLTDP1L3MBTL1
SCHEMBL653422 0.84 MAPT (0.39) MAPTNPSR1RECQLTDP1L3MBTL1
SCHEMBL651184 0.83 MAPT (0.38) MAPTNPSR1RECQLTDP1L3MBTL1
SCHEMBL651186 0.83 MAPT (0.38) MAPTNPSR1RECQLTDP1L3MBTL1
SCHEMBL10176549 0.81 MAPT (0.41) MAPTNPSR1RECQLTDP1L3MBTL1
SCHEMBL650960 0.81 MAPT (0.41) MAPTNPSR1RECQLTDP1L3MBTL1
SCHEMBL10176561 0.81 MAPT (0.39) MAPTNPSR1RECQLTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 MAPT 3657/4885NPSR1 4464/4885RECQL 1217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.